Promino Nutritional Sciences Past Earnings Performance
Past criteria checks 0/6
Promino Nutritional Sciences's earnings have been declining at an average annual rate of -7.1%, while the Personal Products industry saw earnings growing at 9.3% annually. Revenues have been declining at an average rate of 50.7% per year.
Key information
-7.1%
Earnings growth rate
40.5%
EPS growth rate
| Personal Products Industry Growth | 20.9% |
| Revenue growth rate | -50.7% |
| Return on equity | n/a |
| Net Margin | -2,947.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Promino Nutritional Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -10 | 9 | 0 |
| 31 Mar 24 | 0 | -8 | 6 | 0 |
| 31 Dec 23 | 0 | -6 | 4 | 0 |
| 30 Sep 23 | 0 | -7 | 4 | 0 |
| 30 Jun 23 | 1 | -9 | 7 | 0 |
| 31 Mar 23 | 2 | -10 | 8 | 0 |
| 31 Dec 22 | 4 | -10 | 9 | 0 |
| 30 Sep 22 | 4 | -7 | 8 | 0 |
| 30 Jun 22 | 4 | -7 | 9 | 0 |
| 31 Mar 22 | 4 | -8 | 11 | 0 |
| 31 Dec 21 | 2 | -9 | 10 | 0 |
| 30 Sep 21 | 2 | -10 | 11 | 0 |
| 30 Jun 21 | 2 | -12 | 9 | 0 |
| 31 Mar 21 | 1 | -9 | 5 | 0 |
| 31 Dec 20 | 1 | -8 | 4 | 0 |
| 30 Sep 20 | 1 | -6 | 2 | 0 |
| 31 Dec 19 | 2 | -1 | 2 | 0 |
| 31 Dec 18 | 0 | -2 | 1 | 0 |
Quality Earnings: MUSL.F is currently unprofitable.
Growing Profit Margin: MUSL.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MUSL.F is unprofitable, and losses have increased over the past 5 years at a rate of 7.1% per year.
Accelerating Growth: Unable to compare MUSL.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MUSL.F is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (-5.2%).
Return on Equity
High ROE: MUSL.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.